295
Participants
Start Date
January 16, 2013
Primary Completion Date
May 18, 2016
Study Completion Date
May 18, 2016
Placebo
Tablets administered orally twice daily
Rituximab
375 mg/m\^2 administered intravenously weekly for 4 weeks, then every 8 weeks (up to a total of 8 infusions)
Idelalisib
150 mg tablets administered orally twice daily
Semmelweis Egyetem, Budapest
Országos Onkológiai Intézet, Budapest
Western Hospital, Footscray
Saint Vincent's Hospital, Fitzroy
Box Hill Hospital, Box Hill
Monash Medical Centre, Clayton
Debreceni Egyetem Orvos-és Egészségtudományi Centrum, Debrecen
Haematology and Oncology Clinics of Australia at Chermside, Milton
Royal Perth Hospital, Perth
Fiona Stanley Hospital, Murdoch
Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár
Markusovszky Egyetemi Oktatókórház, Szombathely
Icahn School of Medicine at Mount Sinai, New York
Weill Cornell Medical College, New York
Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino
Montefiore Medical Center, The Bronx
Tri-Service General Hospital, Taipei
Perelman Center for Advanced Medicine, Philadelphia
Georgetown University Medical Center, Washington D.C.
Shenandoah Oncology Associates, PC, Winchester
"Azienda Ospedaliero Universitaria (AOU) Maggiore della Carita di Novara", Novara
Hospital Universitario Puerta de Hierro, Majadahonda
Centre Hospitalier Universitaire Brest, Brest
Centro di Riferimento Oncologico di Aviano, Pordenone
University Hospital of Bordeaux, Pessac
Moffitt Cancer Center, Tampa
Florida Cancer Specialists and Research Institute, Fort Myers
Gemeinschaftspraxis Dres. Söling Und Siehl, Kassel
Clearview Cancer Institute, Huntsville
Sarah Cannon Cancer Center, Nashville
Tennessee Oncology, PLLC, Chattanooga
Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna
Hôpital Hôtel-Dieu, Nantes
MetroHealth Medical Center, Cleveland
Signal Point Clinical Research Center, LLC, Middletown
Wayne State University, Detroit
Rabin Medical Center, Petah Tikva
Froedtert Hospital and Medical College of Wisconsin, Milwaukee
Prairie Lakes Healthcare System, Watertown
Centre Hospitalier Régional Universitaire de Lille, Hôpital Claude Huriez, Lille
Centre Hospitalier de Dunkerque, Dunkirk
Azienda Ospedaliera Ospedali Riuniti Marche Nord, Pesaro
Cancer Center of Kansas, Wichita
Centre Léon Bérard, Lyon
Centre Hospitalier Lyon Sud, Pierre-Bénite
Hôpital Necker-Enfants Malades, Paris
Texas Oncology, P.A., Bedford
Center for Cancer and Blood Disorders, PC, Fort Worth
Schwarzwald-Baar Klinikum Villingen-Schwenningen GmbH, Villingen-Schwenningen
Centre Hospitalier de Versailles, Le Chesnay
Brooke Army Medical Center, Fort Sam Houston
Chang Gung Memorial Hospital (CGMH), Kaohsiung City
Ironwood Cancer and Research Center, Chandler
Centre Hospitalier Universitaire de Poitiers Hôpital de la Milétrie, Poitiers
UCLA Medical Center, Los Angeles
Cancer Care Associates, Redondo Beach
Pacific Shores Medical Group, Long Beach
City of Hope Cancer Center, Duarte
Hadassah Medical Organization, Ein Kerem, Jerusalem
Saint Jude Heritage Healthcare, Fullerton
Cancer Center of Santa Barbara, Santa Barbara
Central Coast Medical Oncology Group, Santa Maria
Virginia Mason Medical Center, Seattle
Northwest Medical Specialties, PLLC, Tacoma
Singapore General Hospital, Singapore
National Cancer Centre Singapore, Singapore
Saint Petersburg I.P. Pavlov State Medical University, Saint Petersburg
"FSI V.A. Almazov Federal Centre of Heart, Blood and Endocrinology of Rosmedtechnologies", Saint Petersburg
Gleneagles Medical Centre, Singapore
Ryazan Regional Clinical Hospital, Ryazan
Nizhny Novgorod Regional Clinical Hospital n.a. N.A. Semashko, Nizhny Novgorod
Sverdlovsk Regional Clinical Hospital #1, Yekaterinburg
National Cancer Center Hospital, Chuo-ku
Toranomon Hospital, Minato-ku
National Hospital Organization Nagoya Medical Center, Nagoya
Tohoku University Hospital, Sendai
Middlesex Hospital Cancer Center, Middletown
Comprehensive Cancer Centers of Nevada, Las Vegas
Adelaide Cancer Centre, Kurralta Park
Fakultní nemocnice Hradec Králové, Hradec Králové
Aichi Cancer Center Hospital, Nagoya
Nagoya City University Hospital, Nagoya
National Hospital Organization Kyushu Cancer Center, Minamiku
Kobe City Medical Center General Hospital, Kobe
Tokai University Hospital, Isehara-shi
National Hospital Organization Kumamoto Medical Center, Chuo-ku
Okayama University Hospital, Okayama
Osaka City University Hospital, Osaka
The Cancer Institute Hospital of JFCR, Koto-ku
Malopolskie Centrum Medyczne S.C., Krakow
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Ministerstwa Spraw Wewnetrznych z Warminsko-Mazurskim, Olsztyn
Centrum Onkologii i Hipertermii, Warsaw
Hospital Geral de Santo António do Centro Hospitalar do Porto, Porto
Institutul Clinic Fundeni, Bucharest
Saratov State Medical University, Saratov
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
Asan Medical Center, Seoul
Hospital Universitari Germans Trias i Pujol, Badalona
Skånes Universitetssjukhus, Malmö, Malmo
Barts and The London NHS Trust, London
Mount Vernon Hospital, Middlesex
Sunderland Royal Infirmary, Sunderland
Lead Sponsor
Gilead Sciences
INDUSTRY